Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-85.75%
operating margin TTM
-91.67%
revenue TTM
22.47 Million
revenue per share TTM
0.83$
valuation ratios | |
|---|---|
| pe ratio | -2.14 |
| peg ratio | 0.17 |
| price to book ratio | 0.74 |
| price to sales ratio | 1.93 |
| enterprise value multiple | -5.06 |
| price fair value | 0.74 |
profitability ratios | |
|---|---|
| gross profit margin | 69.4% |
| operating profit margin | -91.67% |
| pretax profit margin | -85.68% |
| net profit margin | -85.75% |
| return on assets | -31.46% |
| return on equity | -30.19% |
| return on capital employed | -37.11% |
liquidity ratio | |
|---|---|
| current ratio | 10.68 |
| quick ratio | 10.68 |
| cash ratio | 9.86 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 51.17 |
| days of payables outstanding | 45.98 |
| cash conversion cycle | 5.19 |
| receivables turnover | 7.13 |
| payables turnover | 7.94 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.44 |
| cash per share | 1.60 |
| operating cash flow per share | -0.44 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Ocuphire Pharma, Inc. (NASDAQ:OCUP) reported earnings?
Ocuphire Pharma, Inc. (OCUP) published its most recent earnings results on 13-08-2024.
What is Ocuphire Pharma, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ocuphire Pharma, Inc. (NASDAQ:OCUP)'s trailing twelve months ROE is -30.19%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ocuphire Pharma, Inc. (OCUP) currently has a ROA of -31.46%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did OCUP's net profit margin stand at?
OCUP reported a profit margin of -85.75% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is OCUP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.68 in the most recent quarter. The quick ratio stood at 10.68, with a Debt/Eq ratio of 0.00.